Department of Epidemiology, School of Public Health and Safety, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran.
Cancer Epidemiol. 2024 Dec;93:102685. doi: 10.1016/j.canep.2024.102685. Epub 2024 Oct 28.
Cancer is projected to become the primary cause of death in the 21st century. Although childhood cancer is relatively rare, it remains a significant contributor to mortality among children. This study examines the geographical distribution of childhood cancer incidence in Iranian provinces using data from the National Cancer Registry between 2014 and 2018.
This registry-based study analyzed data from 14,711 children under 20 diagnosed with common childhood cancers, sourced from the Iranian National Population-based Cancer Registry for the period 2014-2018. The age-standardized incidence rates (ASR) were calculated using direct standardization methods and reported per 1 million person-years. Spatial autocorrelation measures, including global and local indices such as Moran's I and Getis-Ord's G, were employed to identify high-risk and low-risk areas, assess overall spatial dependence, and pinpoint specific clusters and hotspots of incidence rates.
ASR for childhood cancer in Iran was 119.56 per 1 million individuals aged 0-19 years. Boys had a higher ASR (129.98) than girls (107.68). Childhood cancer cases increased from 2765 in 2014 to 3354 in 2018, with leukemia as the most common type, followed by brain and nervous system, lymphoma, bone, and connective and soft tissue cancers. Spatial analysis identified high-risk clusters in central Iran (Isfahan, Yazd, Tehran) and low-risk clusters in the northeast (Kermanshah, West and East Azerbaijan, Kurdistan).
This study highlights high childhood cancer incidence in Iran, particularly among boys and in central regions, with elevated leukemia rates. These findings call for targeted prevention strategies and further research to address geographic and gender disparities and to improve care programs.
癌症预计将成为 21 世纪的主要死因。尽管儿童癌症相对较少见,但它仍是儿童死亡的重要原因之一。本研究使用 2014 年至 2018 年全国癌症登记处的数据,研究了伊朗各省儿童癌症发病率的地理分布。
本基于登记的研究分析了来自伊朗全国人口癌症登记处的 14711 名 20 岁以下确诊为常见儿童癌症的儿童数据,这些儿童来自 2014-2018 年期间。使用直接标准化方法计算年龄标准化发病率 (ASR),并按每 100 万人年报告。采用空间自相关度量,包括全局和局部指标,如 Moran's I 和 Getis-Ord's G,以识别高风险和低风险地区,评估总体空间依赖性,并确定发病率的特定集群和热点。
伊朗儿童癌症的 ASR 为每 10 万名 0-19 岁人群 119.56 人。男孩的 ASR(129.98)高于女孩(107.68)。儿童癌症病例从 2014 年的 2765 例增加到 2018 年的 3354 例,白血病是最常见的类型,其次是脑和神经系统、淋巴瘤、骨、结缔组织和软组织癌。空间分析确定了伊朗中部(伊斯法罕、亚兹德、德黑兰)的高风险集群和东北部(克尔曼沙赫、西阿塞拜疆、东阿塞拜疆、库尔德斯坦)的低风险集群。
本研究强调了伊朗儿童癌症发病率较高,尤其是男孩和中部地区,白血病发病率较高。这些发现需要采取有针对性的预防策略和进一步研究,以解决地理和性别差异,并改善护理计划。